Professionals 362 results
Capabilities 79 results
Practice Area
Practice Area
Practice Area
Experience 99 results
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|December 19, 2024
Winston & Strawn Represents Estrella Immunopharma in US$100 Million Shelf Registration
Experience
|November 12, 2024
Insights & News 1,848 results
Seminar/CLE
|May 13, 2025
2025 Health Care & Life Sciences Summit
Client Alert
|May 13, 2025
|4 Min Read
Recent Administration Actions Implicating Financial Inclusion Could Impact Financial Institutions
In the absence of active enforcement by federal banking regulators, many financial institutions are choosing this moment to take a second look at their compliance policies and procedures. Recent administrative actions implicating access to financial services may particularly require financial institutions to reevaluate their Consumer Due Diligence (CDD) procedures and Consumer Identification Program (CIP).
Speaking Engagement
|May 9, 2025
Other Results 60 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
Site Content
Location